A Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures.

Clinical trial NCT00740623 · COMPLETED

Trial details

NCT number: NCT00740623
Sponsor: SK Life Science, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Epilepsy, Partial, Motor Epilepsy, Complex Partial Epilepsy, Simple Partial Focal Motor Epilepsy

Start date: 2009-01-01
Primary completion: 2009-10-01
Enrollment: 547

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.